首页> 美国卫生研究院文献>Current Neuropharmacology >Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans
【2h】

Functional Neuroanatomy of the Noradrenergic Locus Coeruleus: Its Roles in the Regulation of Arousal and Autonomic Function Part II: Physiological and Pharmacological Manipulations and Pathological Alterations of Locus Coeruleus Activity in Humans

机译:去甲肾上腺皮质蓝斑功能性神经解剖学:其在调节和自主神经功能中的作用第二部分:人类蓝斑蓝素活性的生理学和药理学处理及病理改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The locus coeruleus (LC), the major noradrenergic nucleus of the brain, gives rise to fibres innervating most structures of the neuraxis. Recent advances in neuroscience have helped to unravel the neuronal circuitry controlling a number of physiological functions in which the LC plays a central role. Two such functions are the regulation of arousal and autonomic activity, which are inseparably linked largely via the involvement of the LC. Alterations in LC activity due to physiological or pharmacological manipulations or pathological processes can lead to distinct patterns of change in arousal and autonomic function. Physiological manipulations considered here include the presentation of noxious or anxiety-provoking stimuli and extremes in ambient temperature. The modification of LC-controlled functions by drug administration is discussed in detail, including drugs which directly modify the activity of LC neurones (e.g., via autoreceptors, storage, reuptake) or have an indirect effect through modulating excitatory or inhibitory inputs. The early vulnerability of the LC to the ageing process and to neurodegenerative disease (Parkinson’s and Alzheimer’s diseases) is of considerable clinical significance. In general, physiological manipulations and the administration of stimulant drugs, α2-adrenoceptor antagonists and noradrenaline uptake inhibitors increase LC activity and thus cause heightened arousal and activation of the sympathetic nervous system. In contrast, the administration of sedative drugs, including α2-adrenoceptor agonists, and pathological changes in LC function in neurodegenerative disorders and ageing reduce LC activity and result in sedation and activation of the parasympathetic nervous system.
机译:大脑主要的去甲肾上腺素能细胞核(LC)产生了支配神经元大多数结构的纤维。神经科学的最新进展有助于揭示控制LC发挥重要作用的许多生理功能的神经元电路。唤醒和自主活动的调节是两个这样的功能,它们在很大程度上是通过LC的参与而密不可分的。由于生理或药理操作或病理过程导致的LC活性改变可导致唤醒和自主功能发生明显变化。这里考虑的生理操作包括有害或引起焦虑的刺激和环境温度的极端表现。详细讨论了通过药物施用对LC控制功能的修饰,包括直接修饰LC神经元活性(例如通过自身受体,贮存,再摄取)或通过调节兴奋性或抑制性输入产生间接作用的药物。 LC对衰老过程和神经退行性疾病(帕金森氏病和阿尔茨海默氏病)的早期脆弱性具有重要的临床意义。通常,生理学操作和刺激药物,α2-肾上腺素能受体拮抗剂和去甲肾上腺素摄取抑制剂的给药会增加LC活性,从而引起交感神经系统的觉醒和激活增强。相比之下,包括α2-肾上腺素受体激动剂在内的镇静药物的给药以及神经退行性疾病和衰老中LC功能的病理改变会降低LC活性,并导致副交感神经系统的镇静和激活。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号